Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
British Journal of Clinical Pharmacology
|
September 28, 2020
Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria
Gaby A M Eliesen, Joris van Drongelen, Petra H H van den Broek, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 14, 2018
Corrigendum to 'Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs' [European Journal of Pharmaceutical Sciences 115 (2018) 175-184]
Sylvia Notenboom, Karl M Weigand, Johannes H Proost, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 9, 2018
Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs
Sylvia Notenboom, Karl M Weigand, Johannes H Proost, et al.
Toxicology
|
April 23, 2019
Differential effects of psychoactive substances on human wildtype and polymorphic T356M dopamine transporters (DAT)
Anne Zwartsen, Carlijn H C Litjens, Laura Hondebrink, et al.
Scientific Reports
|
September 17, 2017
Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease
Ria de Haas, Devashish Das, Alejandro Garanto, et al.
Clinical Pharmacokinetics
|
March 10, 2018
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
Stein Schalkwijk, Rob Ter Heine, Angela C Colbers, et al.
Clinical Pharmacokinetics
|
November 12, 2022
Feasibility of a Pragmatic PBPK Modeling Approach: Towards Model-Informed Dosing in Pediatric Clinical Care
Joyce E M van der Heijden, Jolien J M Freriksen, Marika A de Hoop-Sommen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 18, 2024
Human enteroid monolayers as a potential alternative for Ussing chamber and Caco-2 monolayers to study passive permeability and drug efflux
Eva J Streekstra, Marit Keuper-Navis, Jeroen J M W van den Heuvel, et al.
Molecular Pharmaceutics
|
August 9, 2024
Age-Specific ADME Gene Expression in Infant Intestinal Enteroids
Eva J Streekstra, Tom Scheer-Weijers, Michael Bscheider, et al.
Placenta
|
July 5, 2022
Ex vivo dual perfusion of an isolated human placenta cotyledon: Towards protocol standardization and improved inter-centre comparability
Henning Schneider, Christiane Albrecht, Mahmoud S Ahmed, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
British Journal of Clinical Pharmacology
|
September 28, 2020
Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria
Gaby A M Eliesen, Joris van Drongelen, Petra H H van den Broek, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 14, 2018
Corrigendum to 'Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs' [European Journal of Pharmaceutical Sciences 115 (2018) 175-184]
Sylvia Notenboom, Karl M Weigand, Johannes H Proost, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 9, 2018
Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs
Sylvia Notenboom, Karl M Weigand, Johannes H Proost, et al.
Toxicology
|
April 23, 2019
Differential effects of psychoactive substances on human wildtype and polymorphic T356M dopamine transporters (DAT)
Anne Zwartsen, Carlijn H C Litjens, Laura Hondebrink, et al.
Scientific Reports
|
September 17, 2017
Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease
Ria de Haas, Devashish Das, Alejandro Garanto, et al.
Clinical Pharmacokinetics
|
March 10, 2018
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
Stein Schalkwijk, Rob Ter Heine, Angela C Colbers, et al.
Clinical Pharmacokinetics
|
November 12, 2022
Feasibility of a Pragmatic PBPK Modeling Approach: Towards Model-Informed Dosing in Pediatric Clinical Care
Joyce E M van der Heijden, Jolien J M Freriksen, Marika A de Hoop-Sommen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 18, 2024
Human enteroid monolayers as a potential alternative for Ussing chamber and Caco-2 monolayers to study passive permeability and drug efflux
Eva J Streekstra, Marit Keuper-Navis, Jeroen J M W van den Heuvel, et al.
Molecular Pharmaceutics
|
August 9, 2024
Age-Specific ADME Gene Expression in Infant Intestinal Enteroids
Eva J Streekstra, Tom Scheer-Weijers, Michael Bscheider, et al.
Placenta
|
July 5, 2022
Ex vivo dual perfusion of an isolated human placenta cotyledon: Towards protocol standardization and improved inter-centre comparability
Henning Schneider, Christiane Albrecht, Mahmoud S Ahmed, et al.
Page
of 8